<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01504451</url>
  </required_header>
  <id_info>
    <org_study_id>LAAPITUP 2</org_study_id>
    <nct_id>NCT01504451</nct_id>
  </id_info>
  <brief_title>Left Atrial Ablation of Paroxysmal Atrial Fibrillation With Implantable Loop Recorder Follow Up Study: The LAAPITUP 2 Study</brief_title>
  <acronym>LAAPITUP 2</acronym>
  <official_title>Left Atrial Ablation of Paroxysmal Atrial Fibrillation With Implantable Loop Recorder Follow Up Study 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neil Sulke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eastbourne General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to compare three different techniques in ablation of paroxysmal atrial
      fibrillation. Namely, the Medtronic multi-electrode phased radiofrequency ablation system,
      the Biosense Webster irrigated multi-electrode phased radiofrequency ablation system, and
      minimally invasive thoracoscopic surgical ablation. The study hypothesis is that surgical and
      Biosense Webster ablation are non-inferior to Medtronic ablation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A target of 75 participants will be randomised 1:1:1 to one of the three treatment arms. Each
      participant will have an implantable loop recorder (ILR) prior to ablation in order to assess
      AF burden. After ablation, each participant will be followed up for a year. The ILR will be
      used to assess reduction in AF burden.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AF burden</measure>
    <time_frame>12 months after ablation</time_frame>
    <description>Total proportion of time spent in AF as assessed by ILR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to AF recurrence</measure>
    <time_frame>Up to one year</time_frame>
    <description>Time to recurrence of any AF after ablation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first symptomatic AF recurrence</measure>
    <time_frame>Up to one year</time_frame>
    <description>Time to first symptomatic AF recurrence as assessed by ILR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in QoL measures</measure>
    <time_frame>12 months after ablation</time_frame>
    <description>Change in Quality of Life measures assessed by questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Biosense Webster ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biosense Webster irrigated multi-electrode phased radiofrequency AF ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Minimally invasive thoracoscopic surgical AF ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medtronic ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medtronic multi-electrode phased radiofrequency AF ablation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ILR insertion</intervention_name>
    <description>Insertion of implantable loop recorder</description>
    <arm_group_label>Biosense Webster ablation</arm_group_label>
    <arm_group_label>Surgical ablation</arm_group_label>
    <arm_group_label>Medtronic ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AF ablation</intervention_name>
    <description>AF ablation</description>
    <arm_group_label>Biosense Webster ablation</arm_group_label>
    <arm_group_label>Surgical ablation</arm_group_label>
    <arm_group_label>Medtronic ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic paroxysmal AF suitable for AF ablation

          -  Age &gt; 18 years old

          -  Informed consent to participate in this study.

        Exclusion Criteria:

          -  Pre-existing ILRs or permanent pacemakers that do not allow for continuous monitoring
             for AF occurrence, or are not MRI-safe.

          -  Unable to undergo general anaesthesia for AF ablation.

          -  Previous cardiac surgery, such as coronary artery bypass grafting or valvular surgery.

          -  Scheduled for elective cardiac surgery, such as coronary artery bypass grafting or
             valvular surgery.

          -  Previous thoracic surgery.

          -  Participation in a conflicting study.

          -  Potential participants who are mentally incapacitated and cannot consent or comply
             with follow-up

          -  Pregnancy

          -  Other cardiac rhythm disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Sulke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eastbourne General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen S Furniss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eastbourne General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eastbourne General Hospital</name>
      <address>
        <city>Eastbourne</city>
        <state>E Sussex</state>
        <zip>BN21 2UD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Sussex County Hospital</name>
      <address>
        <city>Brighton</city>
        <state>Sussex</state>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2011</study_first_submitted>
  <study_first_submitted_qc>January 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2012</study_first_posted>
  <last_update_submitted>June 25, 2014</last_update_submitted>
  <last_update_submitted_qc>June 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Eastbourne General Hospital</investigator_affiliation>
    <investigator_full_name>Neil Sulke</investigator_full_name>
    <investigator_title>Consultant Cardiologist</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Ablation</keyword>
  <keyword>Implantable loop recorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

